SR Steinhubl, DL Bhatt, DM Brennan, G … - Ann Intern …, 2009 - depts.washington.edu Background: The optimal aspirin dose for the prevention of car- diovascular events remains
controversial. ... Objective: To assess the incidence of and risk factors for adverse clinical outcomes
by investigator-determined aspirin dose in a pri- mary prevention trial. Cited by 12 - Related articles - View as HTML - All 7 versions
MA Duzenli, K Ozdemir, N Aygul, A Soylu, M Tokac - The American Journal of …, 2008 - Elsevier The effects of therapy with aspirin 300 mg/day and with combined aspirin 100 mg/day plus clopidogrel
75 mg/day on platelet function were compared in patients with diabetes mellitus and coronary
artery disease and impaired antiplatelet responses to aspirin 100 mg/day. The study ... Cited by 9 - Related articles - All 28 versions
DSH Bell - Endocrine Practice, 2008 - AACE Submitted for publication March 17, 2008 Accepted for publication May 7, 2008 From the University
of Alabama School of Medicine, Birmingham, Alabama. Address correspondence and reprint
requests to Dr. David SH Bell, Southside Endocrinology, 1020 26th Street South, Room ... Cited by 3 - Related articles - All 2 versions
PA Gurbel, E Mahla, MJ Antonino, US … - J Invasive Cardiol, 2009 - invasivecardiology.com Platelet activation and aggregation are the most critical factors in the generation of ischemic
events, including stent thrombosis and myocardial infarction (MI). Unlike the routine measurement
of blood glucose, cholesterol and C-reactive protein performed during the management of ... Cited by 2 - Related articles - Cached - All 2 versions
PA GURBEL, US TANTRY - Journal of Interventional Cardiology, 2008 - interscience.wiley.com Fundamentally, acute coronary syndromes are platelet-centric diseases, resulting from
platelet-rich thrombi that develop at the site of vessel wall injury. In addition to aggregation, platelets
modulate a plethora of other important pathophysiologic processes, including ... Cited by 2 - Related articles - All 3 versions
D Eleftheriou, V Ganesan - Expert Opin. Pharmacother., 2008 - informahealthcare.com Background: Ischaemic stroke (arterial ischaemic stroke and cerebral sinovenous
thrombosis) is increasingly recognised in childhood and has a significant attendant morbidity
and mortality. Objective: To review the most recent evidence underpinning treatment of ... Cited by 1 - Related articles - All 5 versions
M Vaduganathan, CL Alviar, ME Arikan, A Tellez, S … - American Heart Journal, 2008 - Elsevier Fifty subjects with MS, defined by Adult Treatment Panel III criteria (age 44 ± 9 years, 80%
women, body mass index 35 ± 8 kg/m 2 ) were compared to 50 healthy controls who met none
of the MS criteria (age 40 ± 7 years, 80% women, body mass index: 24 ± 3 kg/m 2 ). Blood ... Cited by 2 - Related articles - All 37 versions
G Anfossi, I Russo, M Trovati - Current Vascular Pharmacology, 2008 - ingentaconnect.com Abstract: Platelets from patients affected by diabetes mellitus and metabolic syndrome show
an impaired sensitivity to physiological antiaggregating agents and an enhanced activation
state, mirrored by an increased expression of membrane activation markers; furthermore, ... Cited by 2 - Related articles - All 2 versions
S SASTRY, MC MORICE - Journal of Interventional Cardiology, 2009 - interscience.wiley.com The introduction of the first generation of drug-eluting stents (DES) in 2002 revolutionized interventional
cardiology by minimizing restenosis. Reports of increased late stent thrombosis with these stents
compared with bare metal stents, probably due to delayed endothelialization, emerged ... Related articles - All 2 versions
F Bednar, P Osmancik, J Hlavicka, V Jedlickova, Z … - Journal of Thrombosis …, 2009 - Springer Abstract Background Aspirin administered early after coronary artery bypass grafting surgery
(CABG) improves graft patency and patients survival. However, the anti- platelet effect of aspirin
seems to be variable and aspirin resistance is currently still being discussed. The aim of ... Related articles
